![FDA Approves Two New Indications for XARELTO® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients FDA Approves Two New Indications for XARELTO® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients](https://mma.prnewswire.com/media/1714128/Xarelo_Liquid_Suspension_Contents.jpg)
FDA Approves Two New Indications for XARELTO® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients
![FDA Approves Two New Indications for XARELTO® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients FDA Approves Two New Indications for XARELTO® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients](https://mma.prnewswire.com/media/1714129/Xarelto_US_Pediatric_Tablet_Oral_Suspension.jpg?p=facebook)
FDA Approves Two New Indications for XARELTO® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients
![New Real-World Study Finds Long-Term XARELTO® (rivaroxaban) Use Resulted in Fewer Strokes and Systemic Emboli Compared to Warfarin in Frail Patients with Non-Valvular Atrial Fibrillation New Real-World Study Finds Long-Term XARELTO® (rivaroxaban) Use Resulted in Fewer Strokes and Systemic Emboli Compared to Warfarin in Frail Patients with Non-Valvular Atrial Fibrillation](https://mma.prnewswire.com/media/645669/Janssen_Pharmaceuticals_Logo.jpg?p=facebook)
New Real-World Study Finds Long-Term XARELTO® (rivaroxaban) Use Resulted in Fewer Strokes and Systemic Emboli Compared to Warfarin in Frail Patients with Non-Valvular Atrial Fibrillation
![Two new real-world studies confirm positive efficacy and safety profile of rivaroxaban in treating and preventing blood clots - Vascular News Two new real-world studies confirm positive efficacy and safety profile of rivaroxaban in treating and preventing blood clots - Vascular News](https://vascularnews.com/wp-content/uploads/sites/7/2016/10/Xarelto_FI.jpg)
Two new real-world studies confirm positive efficacy and safety profile of rivaroxaban in treating and preventing blood clots - Vascular News
![Rivaroxaban more effective than aspirin for preventing blood clots, study results suggest - The Pharmaceutical Journal Rivaroxaban more effective than aspirin for preventing blood clots, study results suggest - The Pharmaceutical Journal](https://pharmaceutical-journal.com/wp-content/uploads/2021/01/xarelto-al-17-scaled.jpg)
Rivaroxaban more effective than aspirin for preventing blood clots, study results suggest - The Pharmaceutical Journal
![ESC: Johnson & Johnson hunts for silver lining as Xarelto bombs blood clot, heart failure studies | Fierce Pharma ESC: Johnson & Johnson hunts for silver lining as Xarelto bombs blood clot, heart failure studies | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1535378173/XareltoBottleA_v1b.jpg/XareltoBottleA_v1b.jpg?VersionId=I_JjPlwhCoFOlQtvHbynH8ClHeSoy_nf)